Together, we propose a model in which TRIP13 activates the PI3K/AKT signaling to transcriptional activation of N-cadherin and inhibition of E-cadherin through the interaction with FLNA and then induces melanoma cell migration, invasion, and EMT (Figure 6(e)). Here, TRIP13 is linked to melanoma.